Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway

Abstract

Background Mast cells are prominent components of solid tumors and exhibit distinct phenotypes in different tumor microenvironments. However, the nature, regulation, function, and clinical relevance of mast cells in human gastric cancer (GC) are presently unknown. Methods Flow cytometry analyses were performed to examine level and phenotype of mast cells in samples from 114 patients with GC. Multivariate analysis of prognostic factors for overall survival was performed using the Cox proportional hazards model. Kaplan-Meier plots for patient survival were performed using the log-rank test. Mast cells, T cells and tumor cells were isolated or generated, stimulated and/or cultured for in vitro and in vivo function assays. Results Patients with GC showed a significantly higher mast cell infiltration in tumors. Mast cell levels increased with tumor progression and independently predicted reduced overall survival. These tumor-infiltrating mast cells accumulated in tumors by CXCL12-CXCR4 chemotaxis. Intratumoral mast cells expressed higher immunosuppressive molecule programmed death-ligand 1 (PD-L1), and mast cells induced by tumors strongly express PD-L1 proteins in both time-dependent and dose-dependent manners. Significant correlations were found between the levels of PD-L1 + mast cells and pro-inflammatory cytokine TNF-α in GC tumors, and tumor-derived TNF-α activated NF-κB signaling pathway to induce mast cell expression of PD-L1. The tumor-infiltrating and tumor-conditioned mast cells effectively suppressed normal T-cell immunity through PD-L1 in vitro, and tumor-conditioned mast cells contributed to the suppression of T-cell immunity and the growth of human GC tumors in vivo; the effect could be reversed by blocking PD-L1 on these mast cells. Conclusion Thus, our results illuminate novel immunosuppressive and protumorigenic roles of mast cells in GC, and also present a novel mechanism in which PD-L1 expressing mast cells link the proinflammatory response to immune tolerance in the GC tumor milieu. Electronic supplementary material The online version of this article (10.1186/s40425-019-0530-3) contains supplementary material, which is available to authorized users.

An immune infiltration signature to predict the overall survival of patients with colon cancer

“…In the PIS model, activated mast cell was found to be the mostly abundant infiltrate in the TME of colon cancer. The density of functional mast cells has been considered as an unfavorable prognostic biomarker in colorectal cancer, which may be linked to its functions about proinflammation, immune suppression, and tumor progression . Another subtype of immune cells that infiltrated highly in the TME was macrophages, including M0, M1, and M2 phenotypes.…”

GC-Derived EVs Enriched with MicroRNA-675-3p Contribute to the MAPK/PD-L1-Mediated Tumor Immune Escape by Targeting CXXC4

“…PD-L1 has been demonstrated to stimulate the immune escape of GC cells. 20 Furthermore, in tumor-infiltrating mast cells, the induction of PD-L1 is able to restrain the proliferation of T cells as well as the production of IFN-γ, 21 in which the suppression of T cells accelerates the progression of GC. 22 Subsequently, we found that the regulation of CXXC4 on PD-L1 could be achieved through the MAPK signaling pathway.…”

Immune Response in H. pylori-Associated Gastritis and Gastric Cancer

“…Mast cells induce PD-L1 expression in both timedependent and dose-dependent manners through TNF-α and its NF-κB signal. T cell response of inhibiting tumors could be reversed by blocking PD-L1, and the fast growth of human GC tumors is not observed [35].…”